330
Participants
Start Date
June 30, 2009
Primary Completion Date
April 30, 2012
Study Completion Date
February 28, 2015
AZD8931
Tablet Oral bid
Paclitaxel
IV once weekly for 3 weeks followed by a week off (repeated cycles)
Placebo
Oral bid (twice daily)
Research Site, Brussels (Jette)
Research Site, Leuven
Research Site, Namur
Research Site, Sint-Niklaas
Research Site, São Paulo
Research Site, Sofia
Research Site, Stara Zagora
Research Site, Varna
Research Site, Vratsa
Research Site, Halifax
Research Site, London
Research Site, Ottawa
Research Site, Brno
Research Site, Jičín
Research Site, Olomouc
Research Site, Prague
Research Site, Praha 4 - Krc
Research Site, Znojmo
Research Site, Villejuif
Research Site, Budapest
Research Site, Debrecen
Research Site, Győr
Research Site, Szeged
Research Site, Lido di Camaiore
Research Site, Modena
Research Site, Treviglio
Research Site, Panama City
Research Site, Lima
Research Site, Barcelona
Research Site, Madrid
Research Site, Valencia
Research Site, Uppsala
Research Site, Chur
Research Site, Glasgow
Research Site, Leicester
Research Site, London
Research Site, Nottingham
Research Site, Surrey
Lead Sponsor
AstraZeneca
INDUSTRY